71 related articles for article (PubMed ID: 16053514)
1. HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling.
Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Takeuchi S; Koeffler HP; Taguchi H
Cancer Sci; 2005 Jul; 96(7):425-33. PubMed ID: 16053514
[TBL] [Abstract][Full Text] [Related]
2.
Kim SY; Park JE; Lee HJ; Sim DY; Ahn CH; Park SY; Shim BS; Kim B; Lee DY; Kim SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474045
[TBL] [Abstract][Full Text] [Related]
3. The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.
Al-Assar O; Bittner MI; Lunardi S; Stratford MR; McKenna WG; Brunner TB
Radiother Oncol; 2016 May; 119(2):300-5. PubMed ID: 27247056
[TBL] [Abstract][Full Text] [Related]
4. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.
Song H; Wang R; Wang S; Lin J
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4700-5. PubMed ID: 15781862
[TBL] [Abstract][Full Text] [Related]
5. Proscillaridin A induces apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in prostate cancer cells.
He Y; Khan M; Yang J; Yao M; Yu S; Gao H
Int J Med Sci; 2018; 15(8):832-839. PubMed ID: 30008594
[TBL] [Abstract][Full Text] [Related]
6. Progress towards the use of HIV protease inhibitors in cancer therapy.
Bernhard EJ; Brunner TB
Cancer Biol Ther; 2008 May; 7(5):636-7. PubMed ID: 18421253
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models.
Alaei M; Nazari SE; Pourali G; Asadnia A; Moetamani-Ahmadi M; Fiuji H; Tanzadehpanah H; Asgharzadeh F; Babaei F; Khojasteh-Leylakoohi F; Saeed Gataa I; Ali Kiani M; Ferns GA; Lam AK; Hassanian SM; Khazaei M; Giovannetti E; Avan A
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568755
[TBL] [Abstract][Full Text] [Related]
8. Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition.
Subeha MR; Goyeneche AA; Bustamante P; Lisio MA; Burnier JV; Telleria CM
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008264
[TBL] [Abstract][Full Text] [Related]
9. Nelfinavir restricts A549 cell growth by inhibiting STAT3 signaling.
He F; Wang G; Xu Z; Huang Z
J Int Med Res; 2021 Jun; 49(6):3000605211014989. PubMed ID: 34167351
[TBL] [Abstract][Full Text] [Related]
10. Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma.
Besse L; Besse A; Stolze SC; Sobh A; Zaal EA; van der Ham AJ; Ruiz M; Phuyal S; Büchler L; Sathianathan M; Florea BI; Borén J; Ståhlman M; Huber J; Bolomsky A; Ludwig H; Hannich JT; Loguinov A; Everts B; Berkers CR; Pilon M; Farhan H; Vulpe CD; Overkleeft HS; Driessen C
Cancer Res; 2021 Sep; 81(17):4581-4593. PubMed ID: 34158378
[TBL] [Abstract][Full Text] [Related]
11. The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir.
Subeha MR; Telleria CM
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228205
[TBL] [Abstract][Full Text] [Related]
12. Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis.
Sun D; Cao M; Li H; Ren J; Shi J; Li N; Chen W
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):24-34. PubMed ID: 32801354
[TBL] [Abstract][Full Text] [Related]
13. The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.
Georgi F; Andriasyan V; Witte R; Murer L; Hemmi S; Yu L; Grove M; Meili N; Kuttler F; Yakimovich A; Turcatti G; Greber UF
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601166
[TBL] [Abstract][Full Text] [Related]
14. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
[TBL] [Abstract][Full Text] [Related]
15. New drugs are not enough‑drug repositioning in oncology: An update.
Armando RG; Mengual Gómez DL; Gomez DE
Int J Oncol; 2020 Mar; 56(3):651-684. PubMed ID: 32124955
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
Barillari G; Monini P; Sgadari C; Ensoli B
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747434
[TBL] [Abstract][Full Text] [Related]
17. The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer
Liebscher S; Koi L; Löck S; Muders MH; Krause M
Clin Transl Radiat Oncol; 2017 Feb; 2():7-12. PubMed ID: 29657993
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F
EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820
[TBL] [Abstract][Full Text] [Related]
19. Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers.
Goda JS; Pachpor T; Basu T; Chopra S; Gota V
Indian J Med Res; 2016 Feb; 143(2):145-59. PubMed ID: 27121513
[TBL] [Abstract][Full Text] [Related]
20. Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.
Meyn RE; Krishnan S; Skinner HD
Clin Cancer Res; 2016 Apr; 22(8):1834-6. PubMed ID: 26920893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
